Current State of LVAD Therapy | Challenges and Opportunities

Disclosure(s):

Mandeep R. Mehra, MD, MSc, FRCP: Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)